(01-3627-JAG) (D NJ). Patent infringement action regarding Barr Laboratories’ ANDA for Aventis’s allergy product Allegra® (fexofenadine hydrochloride). Successful opposition to preliminary injunction and successful launch at risk for Barr.
Every case is different and results depend on their specific circumstances. Prior results do not guarantee a similar outcome.